TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32011589

Group type: EXPERIMENTAL
Intervention: Environmental risk-reduction behaviors (private well testing, radon screening, CO detector ownership)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: CO detector ownership and radon screening
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Demographic factors (white or Asian, college-educated, earn more than $50,000, own homes)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1000
Study: 34855098

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS) services
Number of subjects: 0
Study: 32719073

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 229
Study: 35988205

Group type: EXPERIMENTAL
Intervention: Doxorubicin-loaded nanoparticles
Number of subjects: 88

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 88
Study: 33619220

Group type: EXPERIMENTAL
Intervention: Early palliative care (EPC)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: EPC + inpatient palliative care unit (PCU)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (no EPC)
Number of subjects: 157
Study: 32917223

Group type: EXPERIMENTAL
Intervention: Competency model assessment scale for family physicians
Number of subjects: 0
Study: 35781594

Group type: EXPERIMENTAL
Intervention: Memantine for 6 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 33816430

Group type: EXPERIMENTAL
Intervention: General public awareness of malaria
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Knowledge of transmission routes
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Seeking health advice or treatment
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Testing for malaria
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Demand for long-lasting insecticidal nets
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Shortage of long-lasting insecticidal nets
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Households with children under 5 lacking nets
Number of subjects: 262
Study: 35123290

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT) for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Facilitated peer support (FPS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 40
Study: 33617699

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10 weekly sessions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Clinical Monitoring Only (CMO)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 48
Study: 36232205

Group type: EXPERIMENTAL
Intervention: CHoBI7 Cholera Rapid Response Program
Number of subjects: 284

Group type: COMPARATOR
Intervention: Standard message on oral rehydration solution
Number of subjects: 284
Study: 34636752

Group type: EXPERIMENTAL
Intervention: IV lidocaine (1.5 mg/kg bolus of 1% lidocaine after anesthesia induction followed by a continuous infusion of 2 mg/kg/h up to 1 h after surgery)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline (equal volume to lidocaine)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IV lidocaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: IV lidocaine and saline
Number of subjects: 90
Study: 35272094

Group type: EXPERIMENTAL
Intervention: rmPFC iTBS
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control iTBS
Number of subjects: 35
Study: 34773971

Group type: EXPERIMENTAL
Intervention: Personalized invitation letters
Number of subjects: 1511

Group type: COMPARATOR
Intervention: Generic invitation letters
Number of subjects: 1511
Study: 32566980

Group type: EXPERIMENTAL
Intervention: IPFP preservation
Number of subjects: 42

Group type: COMPARATOR
Intervention: IPFP resection
Number of subjects: 42
Study: 35477430

Group type: EXPERIMENTAL
Intervention: Selective corrective exercises (SCEs) for 8 weeks
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study: 34032710

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy plus adjuvant gemcitabine plus cisplatin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy plus adjuvant 5-fluorouracil plus cisplatin
Number of subjects: 50
Study: 34959205

Group type: EXPERIMENTAL
Intervention: Guideline-positive & RCT-positive individuals (86% ACC/AHA, 88% CCS, 88% NICE, 84% ESC/EAS)
Number of subjects: 79171

Group type: EXPERIMENTAL
Intervention: Guideline-positive & RCT-negative individuals (5-7%)
Number of subjects: 79171

Group type: EXPERIMENTAL
Intervention: Guideline-negative & RCT-positive individuals (28-39%)
Number of subjects: 79171

Group type: EXPERIMENTAL
Intervention: Guideline-negative & RCT-negative individuals (30-31%)
Number of subjects: 79171

Group type: EXPERIMENTAL
Intervention: High-intensity statin therapy
Number of subjects: 79171
Study: 32591573

Group type: EXPERIMENTAL
Intervention: Larger-diameter screws (6.5 mm × 45 mm) and longer screws (6.0 mm × 50 mm) in the normal-density group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Longer screws (6.0 mm × 50 mm) in the osteoporosis group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal-density group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Osteoporosis group
Number of subjects: 60
Study: 33606179

Group type: EXPERIMENTAL
Intervention: ICD implantation for primary prevention
Number of subjects: 177

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 177
Study: 35275991

Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303

Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303
Study: 34130883

Group type: COMPARATOR
Intervention: Moderna vaccine (1 dose)
Number of subjects: 0
Study: 32280035

Group type: EXPERIMENTAL
Intervention: High-quality foster care intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Institutional rearing (neglect)
Number of subjects: 136
Study: 34534511

Group type: EXPERIMENTAL
Intervention: Remdesivir plus standard of care
Number of subjects: 857

Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 857
Study: 32871620

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) filling
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline filling
Number of subjects: 40
Study: 35675092

Group type: EXPERIMENTAL
Intervention: External vein graft support
Number of subjects: 224

Group type: COMPARATOR
Intervention: No support
Number of subjects: 224
Study: 32369436

Group type: EXPERIMENTAL
Intervention: Partial knee replacement
Number of subjects: 528

Group type: COMPARATOR
Intervention: Total knee replacement
Number of subjects: 528
Study: 36383926

Group type: EXPERIMENTAL
Intervention: Axillary Lymph Node Dissection (ALND)
Number of subjects: 1425

Group type: COMPARATOR
Intervention: Axillary Radiotherapy (ART)
Number of subjects: 1425
Study: 34398956

Group type: EXPERIMENTAL
Intervention: LPV/r 400 mg/100 mg twice daily + RBT 150 mg/day (Arm A)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: LPV/r 800 mg/200 mg twice daily + RIF 600 mg/day (Arm B)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: LPV/r 400 mg/100 mg twice daily + RAL 400 mg twice daily + RBT 150 mg/day (Arm C)
Number of subjects: 71
Study: 32423396

Group type: EXPERIMENTAL
Intervention: Journal therapy counseling (3 in-person sessions and 3 telephone sessions)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 70
Study: 34773292

Group type: EXPERIMENTAL
Intervention: Thalidomide 25 mg/d
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Thalidomide 50 mg/d
Number of subjects: 100
Study: 34921525

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 92
Study: 34705578

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 32210157

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs)
Number of subjects: 73

Group type: COMPARATOR
Intervention: No treatment (reference group)
Number of subjects: 73
Study: 35976944

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (1000 μg MK‐7/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 34780632

Group type: EXPERIMENTAL
Intervention: Automated bidet intervention
Number of subjects: 10
Study: 33394994

Group type: EXPERIMENTAL
Intervention: Artificial Intelligence (AI) support system
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pooled reader assessment
Number of subjects: 200
Study: 34198444

Group type: EXPERIMENTAL
Intervention: GA-BPNN (Genetic Algorithm optimized Back Propagation Neural Network)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional methods (subjective prediction based on routine ultrasound and physical examination)
Number of subjects: 80
Study: 36152526

Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic exercise program (bike group), 45 minutes per session, 3 times/week for 3 months.
Number of subjects: 18
Study: 32560932

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Midazolam (0.045 mg/kg)
Number of subjects: 25
Study: 34735762

Group type: EXPERIMENTAL
Intervention: Subanesthetic IV ketamine (0.3 mg/kg)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Caudal 0.125% bupivacaine (1 ml/kg)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Subanesthetic IV ketamine
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Subanesthetic IV ketamine and Caudal bupivacaine
Number of subjects: 141
Study: 35010482

Group type: EXPERIMENTAL
Intervention: I-Walk training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Overground gait training (control)
Number of subjects: 30
Study: 34776421

Group type: EXPERIMENTAL
Intervention: Vibratory stimulation during 2-week task-practice therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: No stimulation (control group) during 2-week task-practice therapy
Number of subjects: 12
Study: 34551995

Group type: EXPERIMENTAL
Intervention: Atrasentan 0.75 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atrasentan
Number of subjects: 0
Study: 35248274

Group type: EXPERIMENTAL
Intervention: Osteopathic Treatment (4 treatments over 8 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control Group (no osteopathic treatment)
Number of subjects: 70
Study: 34464729

Group type: EXPERIMENTAL
Intervention: Single ProGlide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgical cut-down
Number of subjects: 60
Study: 32304514

Group type: EXPERIMENTAL
Intervention: 4 repetition maximum (RM) for 7 sets (4RM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 8 repetition maximum (RM) for 4 sets (8RM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 12 repetition maximum (RM) for 3 sets (12RM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonexercising control group (CON)
Number of subjects: 42
Study: 34192691

Group type: EXPERIMENTAL
Intervention: Sesame powder
Number of subjects: 90

Group type: COMPARATOR
Intervention: Expectant management (control)
Number of subjects: 90
Study: 35012538

Group type: EXPERIMENTAL
Intervention: Regular dose group coaching (5 months)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Extended dose group coaching (5 months + 18 months one-on-one coaching)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Regular dose group coaching with unstructured engagement of scientific advisors
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Regular dose group coaching with structured engagement of scientific advisors
Number of subjects: 72
Study: 33279317

Group type: EXPERIMENTAL
Intervention: SMS group (4,225 participants)
Number of subjects: 6338

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6338
Study: 36280185

Group type: EXPERIMENTAL
Intervention: Nanodropper (10.4 μl of eye drops)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of Care (SOC, 50 μl of eye drops)
Number of subjects: 50
Study: 33650921

Group type: EXPERIMENTAL
Intervention: Auditory-intensive exercises for 20 minutes per day, 5 days per week, for 8 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-auditory intensive games for 20 minutes per day, 5 days per week, for 8 weeks
Number of subjects: 64
Study: 34402784

Group type: EXPERIMENTAL
Intervention: Solriamfetol (150 mg or 300 mg)
Number of subjects: 1714

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg or 400 mg)
Number of subjects: 1714

Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 1714

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1714

Group type: COMPARATOR
Intervention: Comparators (solriamfetol, modafinil, armodafinil)
Number of subjects: 1714
Study: 33290635

Group type: COMPARATOR
Intervention: Conventional symptomatic treatment (Miconaz oral gel, BBC oral spray)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 3% chamomile topical oral gel
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Conventional treatment + 3% chamomile topical oral gel
Number of subjects: 45
Study: 32404040

Group type: EXPERIMENTAL
Intervention: Cardioembolic strokes
Number of subjects: 1429

Group type: COMPARATOR
Intervention: Noncardioembolic strokes
Number of subjects: 1429
Study: 36351174

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: No sodium bicarbonate infusion (control group)
Number of subjects: 0
Study: 33860553

Group type: EXPERIMENTAL
Intervention: Self-help intervention (SH)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Health-care professional discussion (HP)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Written oncofertility educational resource (ER)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 194
Study: 32615462

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 35722108

Group type: EXPERIMENTAL
Intervention: Firehawk stent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xience stent
Number of subjects: 0
Study: 32372750

Group type: EXPERIMENTAL
Intervention: Water Pasteurization Indicators (WAPIs)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: WAPI with a plastic box that floated on the water's surface
Number of subjects: 28

Group type: COMPARATOR
Intervention: WAPI with a wire dipped into the pot
Number of subjects: 28
Study: 32778902

Group type: EXPERIMENTAL
Intervention: Electromechanically assisted gait training (Exowalk®)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physical therapist‐assisted gait training
Number of subjects: 40
Study: 35863693

Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Combined Training (CT)
Number of subjects: 108
Study: 34073203

Group type: EXPERIMENTAL
Intervention: Hybrid model based on 3D structure of peptides; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro experiments with five randomly selected novel ACPs; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 32156842

Group type: EXPERIMENTAL
Intervention: Nano-curcumin (120 mg) for 12 weeks
Number of subjects: 0
Study: 35086229

Group type: EXPERIMENTAL
Intervention: Video counseling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chart counseling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verbal counseling
Number of subjects: 60
Study: 34151819

Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercises using elastic bands at 10 repetitions/set, 3 sets/day, 3 days/week for 4 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 39
Study: 32215728

Group type: EXPERIMENTAL
Intervention: Local, semi-automatic reconstruction
Number of subjects: 20
Study: 35972211

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: OCS (Oral Corticosteroids)
Number of subjects: 0
Study: 34332788

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/Ω-3 fatty acids 4 g (UI-018)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg + placebo (control)
Number of subjects: 200
Study: 33196567

Group type: EXPERIMENTAL
Intervention: Sequential procedure (scleral-fixated IOL implantation followed by DSAEK)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simultaneous procedure (DSAEK with SF IOL)
Number of subjects: 40
Study: 33035186

Group type: EXPERIMENTAL
Intervention: Whole body neutral douche
Number of subjects: 68
Study: 34491207

Group type: EXPERIMENTAL
Intervention: Multistrategy behavioral intervention with choice architecture strategies embedded in the web-based system (n=9 schools)
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Multistrategy behavioral intervention
Number of subjects: 2207

Group type: COMPARATOR
Intervention: Control group (standard web-based ordering system only, n=8 schools)
Number of subjects: 2207
Study: 35728603

Group type: EXPERIMENTAL
Intervention: Bipolar electrocautery device for complete salpingectomy
Number of subjects: 39
Study: 35522325

Group type: EXPERIMENTAL
Intervention: No mask
Number of subjects: 31

Group type: COMPARATOR
Intervention: Surgical mask
Number of subjects: 31

Group type: COMPARATOR
Intervention: FFP-2 mask
Number of subjects: 31
Study: 33904781

Group type: EXPERIMENTAL
Intervention: Meditation monologue
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nature sounds
Number of subjects: 30
Study: 32861614

Group type: EXPERIMENTAL
Intervention: Interprofessional intervention focusing on neuroleptics and potentially inadequate medications
Number of subjects: 862
Study: 34755262

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (127 patients)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No chemotherapy (13 patients)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Incomplete staging surgery
Number of subjects: 140
Study: 32068426

Group type: EXPERIMENTAL
Intervention: MATCH (modular, transdiagnostic, behavioral/cognitive‐behavioral intervention)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: MATCH
Number of subjects: 174

Group type: COMPARATOR
Intervention: MATCH and SMT
Number of subjects: 174

Group type: COMPARATOR
Intervention: SMT (standard manualized treatments)
Number of subjects: 174

Group type: COMPARATOR
Intervention: UC (usual care)
Number of subjects: 174
Study: 35747946

Group type: EXPERIMENTAL
Intervention: HIIT (high-intensity interval training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MCT (moderate-intensity continuous training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 0
Study: 34238553

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 3113

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 3113
Study: 32461298

Group type: EXPERIMENTAL
Intervention: Adaptive radiotherapy using a library of three plans (small, medium and large)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Single-standard plan
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Adaptive radiotherapy
Number of subjects: 62
Study: 34235822

Group type: EXPERIMENTAL
Intervention: Digital educational app
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Concrete materials
Number of subjects: 61

Group type: COMPARATOR
Intervention: Business-as-usual control group
Number of subjects: 61
Study: 33781339

Group type: EXPERIMENTAL
Intervention: Creating a peritoneal flap
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard procedure without creation of a flap (control)
Number of subjects: 300
Study: 32759236

Group type: EXPERIMENTAL
Intervention: Immune checkpoint inhibitors (ICIs)
Number of subjects: 55
Study: 98167534

Group type: EXPERIMENTAL
Intervention: Neural network model
Number of subjects: 1674

Group type: COMPARATOR
Intervention: Logistic regression
Number of subjects: 1674
Study: 36739325

Group type: COMPARATOR
Intervention: 40Hz-tACS_PRE
Number of subjects: 75

Group type: COMPARATOR
Intervention: 40Hz-tACS_ON
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sham
Number of subjects: 75
Study: 33606009

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg twice daily for 7 days)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Azithromycin (single 1-g dose)
Number of subjects: 177
Study: 33457425

Group type: EXPERIMENTAL
Intervention: Metformin (≤1000 mg/d) added to insulin for 24 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Insulin monotherapy
Number of subjects: 17
Study: 33946128

Group type: EXPERIMENTAL
Intervention: Mobilization in the evening (21.00 to 23.00) by trained nurses and physiotherapists
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 46
Study: 32594858

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) sessions with 5 sets of 8-10RM on squat and leg press exercises, recovery intervals of 24h, 48h, or 72h
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) sessions with 5 sets of 8-10RM on squat and leg press exercises, recovery intervals of 48h
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) sessions with 5 sets of 8-10RM on squat and leg press exercises, recovery intervals of 72h
Number of subjects: 14
Study: 34587568

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 33402601

Group type: EXPERIMENTAL
Intervention: Drip intravenous administration of endostar (DE)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Continuous intravenous administration of endostar (CE)
Number of subjects: 98
Study: 32905642

Group type: EXPERIMENTAL
Intervention: Haploidentical stem cell transplantation (Haplo‐HSCT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Matched unrelated donor transplantation (MUD‐HSCT)
Number of subjects: 110
Study: 32398580

Group type: EXPERIMENTAL
Intervention: Transverse approach
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Parasagittal approach
Number of subjects: 60
Study: 34953810

Group type: EXPERIMENTAL
Intervention: Male-specific invitation
Number of subjects: 75810

Group type: EXPERIMENTAL
Intervention: Unisex invitation
Number of subjects: 75810

Group type: EXPERIMENTAL
Intervention: Standard invitation
Number of subjects: 75810

Group type: COMPARATOR
Intervention: No invitation (control)
Number of subjects: 75810